Last reviewed · How we verify
NCT03073629
Assessing Outcomes in ED Patients With RV Failure
NA trial testing Clinical Pathway in Right Heart Failure in 2 participants. Terminated before completion.
23 February 2017
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 1 January 2017 |
| Primary completion | 23 February 2017 |
| Estimated completion | 23 February 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Clinical Pathway
Conditions studied
- Right Heart Failure — all drugs for Right Heart Failure →
Sponsor
Indiana University
Who can join
18 and older, any sex, with Right Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Millions of Americans seek emergency care for acute shortness of breath, and many undergo computerized tomographic pulmonary angiography (CTPA) testing that is negative for acute disease. Management of patients with persistent shortness of breath despite normal testing continues to pose a challenge for clinicians. Right ventricular (RV) failure is a common cause of dyspnea that brings patients to the emergency department (ED), however, it is often not considered in the differential diagnosis, remains unrecognized, or patients are not properly followed up once diagnosed. Delays in diagnosis and management of RV failure are associated with poor outcomes. The investigators propose a novel clinical pathway, which entails identifying and enrolling patients with RV failure in the ED, then referring them to a specialized cardiovascular clinic where they will receive a standardized evaluation and management plan. Our hypothesis is that management of RV failure, through this pathway, will improve patient outcomes when compared to standard care. The primary outcome will assess 1-year unscheduled healthcare visits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03073629
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Clinical Pathway
Trials testing the same drug.
- NCT02660268 — Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections · NA · completed
Other recruiting trials for Right Heart Failure
Currently open trials in the same condition.
- NCT06053580 — Repurposing Valsartan May Protect Against Pulmonary Hypertension · Phase 2 · recruiting
- NCT06039176 — Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future · recruiting
- NCT05179616 — Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair · recruiting
- NCT06023134 — Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure · active not recruiting
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03073629 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 15 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03073629.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing